Alemtuzumab is a
monoclonal antibody that attaches itself to a protein
called CD52. This protein is found on the surface of some cancer cells,
chronic lymphocytic leukemia (CLL) cells. It helps
your immune system see the cancer cell as something that needs to be
Why It Is Used
Alemtuzumab may be used by itself or
in combination with other drugs to treat chronic lymphocytic leukemia (CLL).
Alemtuzumab is sometimes used in
clinical trials to treat other
types of leukemia.
How Well It Works
For people who have CLL and who have
not improved with other chemotherapy drugs such as cyclophosphamide,
fludarabine, or rituximab (or a combination of these), alemtuzumab can be an
Common side effects include:
immune system, which increases your risk of infection.
Low blood counts, which may increase your risk of infection or
How this information was developed to help you make better health decisions.